CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: Azithromycin for COVID-19 Treatment in Outpatients Nationwide [Phase 3]
Summary
Phase 3 clinical trial of azithromycin for outpatient treatment of COVID-19 was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas M. Lietman | Conditions: COVID-19, SARS-CoV-2 | Phase 3 | Status: TERMINATED | Results posted: 2021-09-09